...
首页> 外文期刊>Medical hypotheses >The triblock copolymers hydrogel through intracameral injection may be a new potential ophthalmic drug delivery with antiscaring drugs after glaucoma filtration surgery
【24h】

The triblock copolymers hydrogel through intracameral injection may be a new potential ophthalmic drug delivery with antiscaring drugs after glaucoma filtration surgery

机译:通过前房内注射的三嵌段共聚物水凝胶可能是青光眼滤过术后潜在的新型抗眼药药物

获取原文
获取原文并翻译 | 示例
           

摘要

The hyperplasia of fiber cell at operation area cause scarring lead to the failure after glaucoma filtration surgery. People are looking for more safe and effective way to advance the success rate in operation. There are many researches demonstrated that ophthalmic drug delivery system can be a treatment. Among this, some biodegradable and thermosensitive triblock copolymers hydrogel are novel candidate for ocular drug release system. But whether they can be used to restrain the hyperplasia of fiber cell through intracameral injection after glaucoma filtration surgery, the research have not been reported. So it suggested a new hypothesis for intracameral injection of the triblock copolymers hydrogel as a new potential in situ sustained ophthalmic drug delivery system with antiscaring formation after glaucoma filtration surgery. Indicating that the new nanomaterials through intracameral injection treating complication of glaucoma filtration surgery is hoped to be a creative and promising ophthalmic drug delivery system in the future.
机译:手术区纤维细胞增生引起瘢痕形成,导致青光眼滤过术后失败。人们正在寻找更安全有效的方法来提高手术的成功率。有许多研究表明,眼科给药系统可以作为一种治疗方法。其中,一些可生物降解和热敏性的三嵌段共聚物水凝胶是眼药释放系统的新型候选物。但是,是否可以通过青光眼滤过术后前房内注射将其用于抑制纤维细胞增生,尚无相关研究报道。因此,它为三嵌段共聚物水凝胶的前房内注射提出了一种新的假设,认为这是一种在青光眼滤过术后形成具有抗瘢痕形成的新的潜在的原位持续眼药递送系统。指出通过前房内注射治疗青光眼滤过手术并发症的新型纳米材料有望在未来成为一种创新且有希望的眼科药物递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号